BIOTECHNOLOGY  ENTREPRENEURSHIP

BOOT CAMP 2017

Created by Academia; Supported by Industry 

Founded in 2005 by Carnegie Mellon University & Wharton School Faculty

 

Thani Jambulingam, PhD

Professor
Pfizer Fellow, Arrupe Research Fellow
Department of Pharmaceutical and Health Care Marketing
St. Joseph’s University

Thani Jambulingam Ph.D. is a Professor in the Department of Pharmaceutical and Healthcare Marketing at St Joseph’s University, Erivan K. Haub School of Business, in Philadelphia, Pennsylvania, USA. Dr. Jambulingam teaches both in the Executive Pharmaceutical & Healthcare MBA program and the undergraduate program in Pharmaceutical and Healthcare Marketing. He has served as the chair of the Department for 8 years and launched the first EMBA online program at SJU in 2002. He is trained at Harvard in case method for teaching. Dr Jambulingam worked in the Glaxo for several years in marketing before earning his Ph.D., at the University of Wisconsin, Madison, USA.

Dr. Jambulingam’s research interests are in pharmaceutical and healthcare innovation strategy and marketing. His work has been published in several refereed academic journals and trade publications in marketing, and management. Dr. Jambulingam has served as the external reader for Ph.D. dissertations at Columbia University.  Dr. Jambulingam is a visiting Professor for the Wharton MBA program in their global programs in India. He is also a faculty at the Biotechnology Entrepreneurship Bootcamp held every year during the BIO International Convention. He has served as a consultant and facilitated educational training sessions in strategy for senior leadership and/or brand teams within several small, mid and large pharmaceutical firms including Alkermes, Abbott, Astra Zeneca, Merck, Novo Nordisk, Pfizer, Solvay and Procter & Gamble. Recently Dr. Jambulingam, as a Pfizer fellow, spent a year at Pfizer with the Prevnar Global Commercial Team contributing to developing a healthy aging platform, franchise positioning, vaccine business strategy for emerging markets, and pediatric expanded age expansion strategy (life cycle management). He conducted strategy session for executive leadership within the specialty care division of Pfizer.

Dr. Jambulingam has received outstanding teaching and research awards at SJU. He was inducted into Rho Chi, the honor society for pharmacy and Beta Gama Sigma, the honor society for business. Dr. Jambulingam servers in the advisory board of two startup biotech/pharma companies

.